đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Status
Completed
Location
St George's Vaccien Institute
Start Date
2013-07
Trial ID
NCT01896596
The purpose of the present study is to demonstrate that the changes in the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-05
Trial ID
NCT00808444
To assess the long-term efficacy and safety of the subjects during the thir...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-12
Trial ID
NCT00420316
Treatments Being Tested
The purpose of this study is to assess the immunogenicity in terms of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-18
Trial ID
NCT00533507
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01983540
The purpose of this study is to assess the immunogenicity in terms of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-03
Trial ID
NCT00489554
Treatments Being Tested
The purpose of this study is to evaluate safety, to demonstrate lot-to-lot ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-18
Trial ID
NCT01000974
To assess the safety and reactogenicity of the DTPa-HBV-IPV/Hib vaccine and...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-12-01
Trial ID
NCT00325143
Treatments Being Tested
The purposes of this study: * To evaluate the immunogenicity, safety and r...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02-17
Trial ID
NCT00829010
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-16
Trial ID
NCT02096263